IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Splenic Marginal Zone Lymphoma
City of Hope Medical Centermonoclonal_antibodyPhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 81/ 100
Competitive context
31 Active assets in the Splenic Marginal Zone Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 2 | BB |
Cediranib National Cancer Institute (NCI) | Phase 2 | BB |
DEXAMETHASONE Izidore Lossos, MD | Phase 2 | BB |
Zanubrutinib SWOG Cancer Research Network | Phase 3 | BB |
VINCRISTINE SULFATE SWOG Cancer Research Network | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →